Astrocytes, once relegated to a mere supportive role in the central nervous system, are now recognized as a heterogeneous class of cells with many important and diverse functions. Major astrocyte functions can be grouped into three categories: guidance and support of neuronal migration during development, maintenance of the neural microenvironment, and modulation of immune reactions by serving as antigen-presenting cells. The concept of astrocytic heterogeneity is critical to understanding the functions and reactions of these cells in disease. Astrocytes from different regions of the brain have diverse biochemical characteristics and may respond in different ways to a variety of injuries. Astrocytic swelling and hypertrophy-hyperplasia are two common reactions to injury. This review covers the morphologic and pathophysiologic findings, time course, and determinants of these two responses. In addition to these common reactions, astrocytes may play a primary role in certain diseases, including epilepsy, neurological dysfunction in liver disease, neurodegenerative disorders such as Parkinson's and Huntington's diseases, and demyelination. Evidence supporting primary involvement of astrocytes in these diseases will be considered.
Neuroglia were recognized as distinct cellular elements in the central nervous system (CNS) in the late 1 8 0 0~.~~~ Mihaly von Lenhossek in 1895 proposed the name astrocyte to identify a specific class of these cells and suggested that the term neuroglia be used to encompass all supporting cells in the CNS. 256 Astrocytes have long been considered as playing structural and supporting roles, reacting sluggishly and in a largely stereotypical manner to injury and disease. Rarely have astrocytes been identified as playing a primary part in diseases of the CNS. Mainly because of advances in cell culture and more specific ways to identify these cells, knowledge of astrocytic development, form, function, and roles in disease has increased dramatically. Astrocytes are estimated to comprise as much as 20-25% or even up to 50% of the total volume in some brain a r e a~. * I . ~~~ Although with increasing brain weight there is a decrease in the number of neurons across several species, in the same species the ratio of glia to neurons increases. Astrocytic density then remains relatively constant or may even increase in more phylogenetically advanced species. 256 These findings indicate the importance of astrocytes in the CNS.
As is true of many aspects of cell biology and medicine, knowledge gained from studies in one species may not apply to other animals or to human beings. Likewise, information from in vitro studies may not be representative of astrocytes in situ8' In an organ as biochemically and functionally complex as the brain, knowledge gained from the study of astrocytes in spe-cific areas may not apply to other regions of the CNS. The concept of astrocytic morphologic, biochemical, and functional heterogeneity is important to remember when attempting to understand the diverse functions of astrocytes and their reactions in disease.81.82.85.95J30. 201.268 This article provides an overview of current concepts of astrocyte morphology, function, and general reactions in disease and details specific diseases in which astrocytes may play a primary part. It is hoped that this review will instill a new appreciation for this dynamic cell in the CNS.
Astrocyte Morphology
Astrocytes, as the name suggests, are process-bearing stellate or star-shaped cells distributed throughout the brain and spinal cord. Astrocytes are traditionally divided into protoplasmic and fibrous types based on their morphologic appearance and distribution in the central nervous system (CNS).14. 93,194.200 In most instances, protoplasmic astrocytes predominate in gray matter and fibrous astrocytes are most common in white matter. With routine staining, such as hematoxylin and eosin, and the light microscope, astrocytes can be viewed as pale-staining oval to round (protoplasmic) or lobate (fibrous) nuclei with little if any discernible cytoplasm. Distinction between astrocytes and small neurons may be difficult, but small neurons have distinct nucleoli whereas astrocytes have an indistinct or inapparent nucle01us.~~ Only after metallic impregnation (Figs. 1, 2), other special stains (Figs. 3, 4) , and immunocytochemical examination (Fig. 5 ) can the process-bearing nature of these cells be fully appreciated.14.93.200 The major identifying ultrastructural feature of astrocytes is the presence of intermediate filaments (glial fibrils), which are much more prominent in fibrous than in protoplasmic a s t r o c y t e~.~~~.~~~ The major component of glial fibrils, glial fibrillary acidic protein (GFAP), is relatively specific for astrocytes in the CNS.13.46 This specificity ofGFAP has been a major breakthrough in the study of astrocytes both in situ and in cell culture. 117.145.200.238 A second classification of astrocytes based on morphologic and immunohistochemical findings has been in vitro studies of mainly rat optic nerves, astrocytes have been divided into two categories: type 1 and type 2 ( Table 1 ). These two types of astrocytes are thought to develop from different progenitor cells. The progenitor cell for type 1 astrocytes is believed to be com-prOpOSed~51. 147.164.165,200,202.203.246.268 In both in viva and mitted to the astrocytic lineage, whereas the type 2 cell is thought to derive from bipotential progenitor cells (termed 0-2A) that can develop into either type 2 astrocytes or oligodendrocytes. Although there is little doubt that astrocytes arise from pluripotential stem cell(s), there is controversy concerning the validity and applicability of this classification in other areas of the CNS, especially regarding cells of the 0-2A lineage19~146~17s~200.242. 243 There are several reasons for this controversy.19 The type 2 astrocytic phenotype is only transiently expressed in vitro. Additionally, cells that express ganglioside GD3 (a marker for oligodendrocytes) as well as GFAP have not been demonstrated in vivo. In the mouse, the A2B5 monoclonal antibody binds to type I1 astrocytes and to a subpopulation of type 1 ~e 1 l s . l~~
Other studies on the timing of astrocytic differentiation are at odds with the temporal pattern of cellular generation as originally proposed for the type 2 a~t r o c y t e .~~~ Despite this controversy, the as- trocyte type 1 and 2 terminology has been integrated into the medical literature. Type 1 and type 2 astrocytes are proposed to be analogous to protoplasmic and fibrous astrocytes, respectively.'65 At present, however, it would seem prudent to view these two schemes independently; the two categories are not mutually exclusive but neither are they inclusive, based on available data.
Approximately 50% of the glial cell population in the brain consists of astrocytes, and these cells are up to ten times more numerous than neurons in the mammalian CNS.*I Astrocytes have intimate relationships with other cellular and structural components of the CNS (Figs. 1,6 ). Astrocytic processes invest cell bodies and processes of neurons, surround individual or clusters of synapses, and encircle the nodes of Ranvier of myelinated axons. Astrocytic processes form a dense subpial network of fibers known as the glia limitans. Processes of astrocytes also form a subependymal network in some areas of the CNS. Astrocytic foot processes completely encircle blood vessels, which led some earlier investigators to erroneously identify this association as the site of the blood-brain barrier.l" These relationships indicate that astrocytes provide some structural support in the CNS and, more importantly, play vital functional roles.
Astrocytes possess two membrane specializations, gap junctions and orthongonal assemblies, that are intimately associated with certain aspects of astrocytic function. Gap are composed of hollow transmembrane proteins, termed connexons, that join with a homologous protein on adjacent cells to create hydrophobic channels that allow the interchange between coupled cells of small molecules with molecular weights less than l,000.41.169 Such molecules include ions, oligosaccharides, amino acids, nucleotides, small peptides, and certain trophic f a~t 0 r s . I~~ Gap junctions that couple cells of the same kind are said to be homologous, and astrocyte-astrocyte junctions are numerous. Homologous gap junctions also occur between ependymal cells and between oligodendrocytes. In addition, there are heterologous gap junctions, which form astrocyte-ependymal cell and astrocyteoligodendrocyte connections. 169 A functional syncytium extends via gap junctions from the ependyma to the pial surface and allows the exchange of molecules throughout the glial cell compartment, and the major component of this syncytium is the astrocyte. Because heterologous astrocyte-oligodendrocyte junctions far outnumber the few (if any) homologous oligodendrocyte junctions, it is theorized that oligodendrocytes represent a "blind-ended'' component of this sys-Astrocytes express connexin 43.41.42 The distribution of gap junctions and expression or concentration of connexin 43 is not uniform throughout the brain.' Even in specific brain regions such as the hypothalamus, there is variation in gap junction expression.' Neurons in some way may regulate the expression of connexin 43 in astrocytes. Neuronal degeneration and loss experimentally induced by kainic acid injection in rat brain is followed by an almost total depletion of connexin 43 immunoreactivity. 261 These results illustrate ways in which astrocytes may be morphologically, biochemically, and functionally diverse and how neuron-astroglia interactions can modify astrocytic function. Orthogonal assemblies are paracrystalline arrays composed of 7-nm particles that can be viewed only in freeze-fracture preparations. 126.169.200 These arrays are most numerous on the astrocytic endfeet facing and surrounding blood vessels and on the astrocytic processes facing the pia mater. Orthogonal assemblies may function in cell adhesion or, more importantly, in transport of substances between astrocytes and blood or cerebrospinal fluid.'69 The interaction of astrocytes and cerebral endothelial cells seems to be important in the development of these arrays. Astrocytes cocultured with cerebral endothelial cells develop higher concentrations of orthogonal assemblies than do astrocytes grown alone.16,251 Cocultures also stimulate aggregation of these arrays in numbers approaching those observed in vivo. Fibroblasts, smooth muscle cells, and endothelial cells from noncerebral blood vessels did not induce formation and aggregation of these assemblies, indicating that the interaction is specific for astrocytes and cerebral endothelium. If the orthogonal assemblies are indeed related to astrocytic transport functions, they would provide a link among the glial cell syncytium, blood, and cerebrospinal fluid.
Astrocytic Functions
Astrocytes, by virtue of numbers and relationships with other structural and cellular components, play a diverse and vital part in development and normal functioning of the central nervous system (CNS). Several important and some miscellaneous functions of astrocytes are listed along with pertinent references in Table 2 . Although these functions are listed separately, there is considerable overlap among these various roles, especially regarding development of the nervous system and the maintenance of the extracellular environment within the CNS. It is not possible to cover all aspects of astrocytic function in depth or to adequately discuss the experimental data supporting these concepts. A thorough understanding of these various functions is necessary, however, to appreciate fully the reactions of astrocytes in disease.
Guidance of neuronal migration
There is support for the general concept that neurons migrate along the processes of glial cells during development of the CNS. Glial cells that provide this migratory scaffold are termed radial glia. Immunocytochemical studies have shown that the processes of radial glia contain vimentin and glial fibrillary acidic protein; these cells are believed to be immature astrocytes. During further maturation of the CNS, these cells lose vimentin and differentiate into astrocytes after neuronal migration is complete.
Extracellular matrix proteins and adhesion molecules
Astrocytes are the major source of extracellular matrix proteins and adhesion molecules in the CNS. These molecules are important in the development and maintenance of structural relationships and probably play a part in repair and regeneration of the CNS following injury. Examples of these molecules include neural cell adhesion molecule, laminin, fibronectin, and cytotactin J 1. Astrocytes also possess receptors for these matrix proteins. 
Neurotrophic and neurite-promoting factors
Astrocytes are required for neuronal survival and neurite formation. In general, it has been proposed that astrocytic products required for neuronal survival are soluble factors, whereas neurite formation and elongation require the presence of substrate-bound matrix proteins or the physical presence of astrocytes. Examples of neurotrophic factors include small molecular weight molecules such as pyruvate and others required for neuronal energy metabolism. Extracellular matrix proteins, such as laminin, are an example of neuritepromoting factors. Astrocytes also produce soluble factors such as nerve growth factor and S-100 protein, which may promote neurite growth and elongation. Coculture of astrocytes and neurons in some way may also reciprocally influence cell morphology and biochemical differentiation. 
Angiogenesis
Steps involved in angiogenesis include endothelial activation, basement membrane dissolution, replication and migration of endothelial cells to form cords and tubes, and maturation with reconstitution of the basement membrane. When cocultured with astrocytes, endothelial cells are induced to form capillarylike structures. This interaction requires physical contact; endothelial cells that are separated from astrocytes by a porous membrane fail to form capillarylike structures. In addition to the endothelial reorganization, laminin is produced and concentrated in a dense linear band at the astrocyte+ndothelial cell interface, suggesting basement membrane formation. Astrocytes apparently are involved in at least some stages of angi-ogenesis and this may be important in repair of the CNS.
Blood-brain barrier
There is little question that astrocytic endfeet are not the structural or anatomical site of the blood-brain barrier (BBB), as was once believed. The restrictive functions of the BBB are attributed to tight junctions between cerebral endothelial cells and the selective permeability of these cells. Apart from possibly providing structural support and facilitating transport of molecules between the glial syncytium and the vasculature via orthogonal arrays, how else might astrocytes influence these barrier characteristics? There is both in vivo and in vitro evidence that astrocytes play a role in the induction and maintenance of the BBB. Astrocytes are believed responsible for the formation of the tight junctions between endothelial cells. In addition to the induction of this key structural component of the BBB, astrocytes also modify the transport properties of cerebral endothelium. Results of cell culture studies suggest that factors produced by astrocytes increase the capacity of glucose transport systems and enhance neutral amino acid transport in endothelial cells. Additionally, astrocytes modify the polarity of the transport system for neutral amino acids. Astrocytes also alter enzyme activity in cerebral endothelium. Activities of Na+-K+-ATPase and alkaline phosphatase are increased. Soluble products from astrocytes induce the synthesis of gamma-glutamyl transpeptidase by endothelial cells. Soluble astrocytic products reduce endothelial cellular mitotic activity, suggesting that these products stimulate the development of more mature cellular characteristics.
Neurotransmission
Neurotransmission involves storage and release of transmitter molecules from terminals at the synaptic junction and interaction of the transmitters with postsynaptic receptors. Termination of transmission requires uptake of these molecules from the synaptic cleft. The transmitters may then be reused or metabolized. High-affinity uptake systems for neurotransmitters are well recognized in neurons. Astrocytes also possess uptake systems for a variety of these molecules and, because of their distribution and spatial relationship to synapses, play a key part in neurotransmission. There is considerable variability in the capacity of these uptake systems, not only for the different transmitters but in different regions of the brain. For instance, uptake of the inhibitory transmitter gamma-amino butyric acid is greater in neurons than in astrocytes. Uptake of the excitatory amino acid glutamate is mainly accomplished by astrocytes as opposed to neurons. The capacity for glutamate uptake by astrocytes is greater in those regions of the brain that receive glutaminergic innervation. The fate of neurotransmitters after uptake into astrocytes varies. Glutamate can be converted to glutamine by the enzyme glutamine synthetase. This enzyme was thought to be localized only in astrocytes and especially in areas receiving glutaminergic innervation. However, more recent studies have shown that oligodendrocytes also contain this enzyme. After conversion, glutamine can then be released extracellularly for reuptake by neurons for conversion to gammaamino butyric acid or reconversion to glutamate. For other transmitters, such as dopamine, astrocytic uptake and catabolism is followed by release of its metabolites extracellularly or possibly to the blood or cerebrospinal fluid. Although these examples are grossly oversimplified, they illustrate the biochemical heterogeneity of astrocytes and the parts these cells play in neurotransmission.
Astrocytes also possess a variety of receptors for neurotransmitters and neuroactive peptides. Although the exact significance of these receptors is unknown, some sort of communication between neurons and astrocytes may orchestrate the supportive functions of astrocytes during neuronal activity. A common response of astrocytes to receptor stimulation is increase in levels of CAMP. One primary consequence of increased CAMP is protein phosphorylation. Other responses to stimulation of these receptors include altered permeability of ionic channels, Ca2+ mobilization, increased glycogenolysis, production of neurotrophic factors, changes in neurotransmitter uptake, and changes in levels of certain enzymes, and in cell culture there is a change in the morphologic appearance of astrocytes from flat polygonal to large process-bearing cells.
Regulation of pH, ion concentrations, and osmolarity
Cellular depolarization that occurs during neurotransmission results in potentially dramatic changes in extracellular pH, ion concentrations, and osmolarity. These changes in the cerebral microenvironment must be strictly controlled for the continuance of normal neuronal activity. Astrocytes play a major if not primary role in the maintenance of the extracellular environment. Glial cells contain the enzyme carbonic anhydrase, which plays an integral part in regulating pH. This enzyme was at one time believed to be limited to oligodendrocytes, but further work has confirmed its presence in astrocytes as well. Astrocytes also contain ionic channels for K+, Na', C1-, HC03-, and Ca2+, and receptor-mediated neuron-glia communication may regulate these channels. An example of ionic events that occur during neurotransmission is the marked flux of K+ into the extracellular space. Astrocytes accumulate this ion, and via gap junctions the K+ can be moved away from areas of high to areas of low neuronal activity, to the blood, or to cerebrospinal fluid. This concept, known as spatial buffering, emphasizes the importance of the glial syncytium in maintaining the microenvironment.
Detoxification
Astrocytes may play a primary part in preventing the buildup of toxic substances in the CNS. The toxicity of the excitatory amino acid neurotransmitters such as glutamate is well recognized. Uptake and metabolism of these neurotransmitters affects neurotransmission and prevents accumulation of neurotoxic concentrations of these amino acids. Via glutamine synthetase, astrocytes play a primary role in ammonia metabolism, preventing accumulation of this potentially toxic ion. Astrocytes may also participate in the uptake and sequestration of certain heavy metals, such as lead. Astrocytes contain metal binding proteins, such as metallothionein. These proteins involved in cellular metal metabolism could be involved in the sequestration of certain metals, preventing their accumulation to toxic levels.
Phagocytosis and immune functions
Based on the presence of the BBB and the lack of a significant resident lymphoid population and lymphatic drainage, the CNS was once viewed as an immunopriviledged site, isolated from the body's immune system. It now seems certain that astrocytes serve as a liaison between the CNS and the immune system. In this role, astrocytes function much like macrophages, capable of phagocytosis and of acting as antigen-presenting cells. As modulators of immune function, astrocytes can be induced to express and/or excrete certain molecules that contribute to and facilitate immune reactions ( Table 3) . Astrocytes do not normally express antigens of the major histocompatibility complex (MHC) or they express them only at low concentrations. MHC expression can be induced by a variety offactors, including some viruses and interferon (1FN)-Vet Pathol 3 1 2 , 1994 gamma. Additionally, although tumor necrosis factor (TNF) alone does not induce expression of these antigens, it increases their expression in concert with other factors such as IFN-gamma. There are also inhibitors of MHC expression. Inhibitors that have been recognized include transforming growth factor-beta, the neurotransmitters glutamate and norepinephrine, and the compound dibutyryl CAMP, which is known to induce characteristics of reactive astrocytes in cell culture. Adhesion molecules such as intercellular adhesion molecule (ICAM) may facilitate astrocyte-lymphocyte interactions or possibly the entry of lymphocytes into the CNS. ICAM serves as a ligand for lymphocyte function-associated protein expressed on the surface of lymphocytes. Induction of ICAM expression is increased following exposure of astrocytes to supernatant of phytohemagglutinin-stimulated lymphocytes, lipopolysaccharide, IFN-gamma, and interleukin-1. For the cytokines, certain viruses and lipopolysaccharide may stimulate the production of astrocytic TNF, interleukin-1 and -6, and IF".
Miscellaneous functions
A variety of additional functions have been proposed for astrocytes. One such function is the transport of large molecules in the CNS; astrocytes seem capable of receptor-mediated endocytosis of macromolecules, translocation, and exocytosis. The brain may be protected from oxidative damage by the presence of glutathione in astrocytes. Astrocytes may also be involved in some aspects of neurohormonal secretion. Neurohypophyseal astrocytes insert or retract their processes between neuroendocrine cell bodies depending on the needs for certain hormones, such as in times of dehydration or during lactation.
Astrocytic Reactions in Disease
Two common astrocytic reactions that occur in a variety of disease states are cellular swelling and hypertrophy-hyperplasia. These two reactions are not mutually exclusive; both can occur in the CNS simultaneously. Astrocytic swelling potentially represents a more acute change, whereas hypertrophy-hyperplasia requires some time to develop.
Astrocytic swelling
Swelling of astrocytic cell bodies and perineural and perivascular processes is a common near-terminal or postmortem change in the brains of individuals dying from a variety of causes.93 This "artifactual" swelling, however, may develop by many of the same mechanisms that produce swelling after various types of central nervous system (CNS) injury. The precise molecular pathogenesis of astrocytic swelling is beginning to be unraveled, as are the mechanisms involved in neu-ronal necrosis in certain types of injury. These mechanisms revolve around events that occur during neural transmission and the functions of astrocytes in their regulation of the microenvironment.
Activity-dependent astrocytic swelling. The normal extracellular space in the brain is estimated at 15-20% by volume.20y During neuronal activity with resultant ionic fluxes and accumulation of neurotransmitter molecules, this space may contract by as much as 30%. This shrinkage in the extracellular space is due primanly to astrocytic swelling. A significant event during normal neuronal depolarization is a marked increase in extracellular K+ concentration ([K'],) with influx of K+ into astrocytes and increased intracellular K+ con-
). This flux of K+ into astrocytes results
This K+-induced swelling is due, at least in part, to increased intracellular o~m o l a r i t y .~~~ Neurotransmitters, such as the excitatory amino acid glutamate, may also be involved in astrocytic swelling during neuronal a~t i v i t y .~~.~~. ]
I8.I2O
This effect of glutamate is mediated in part by increased [K'], as well as by a direct action.264 Glutamate receptor stimulation and cellular swelling are associated with increased "a+], and [Caz+],, but the exact mechanism of the cellular swelling is not fully under-Astrocytic swelling in disease. A variety of CNS disorders, such as head trauma, hypoxia-ischemia, hypoglycemia, status epilepticus, and hyperammonemia, are accompanied by astrocytic swelling, which in some cases may be the earliest or only detectable change. 118.179.182.263 In these disorders there may be marked changes in extracellular ionic concentrations, including increased K+ and decreases in Na+, C1-, and Ca", decreased extracellular pH, and/or accumulations of neurotransmitters such as the excitatory amino acids. At least some of the mechanisms responsible for activity-dependent astrocytic swelling seem to mediate the astrocytic swelling observed in these disorders. In addition to the effects of increased [K'], and [Ca'+Ii, other ionic transport systems take part in astrocytic swelling. Of these, Na+/H+ and Cl-/HCO,-exchange systems appear to be involved. 1n8.1 17.' 18.239 Direct evidence for this comes from findings that inhibitors of the transport exchange systems diminish or abolish astrocytic swelling after head injury.108.1 14239 In some types of CNS injury such as ischemia, intracellular concentrations of lactate increase, lowering the pH and resulting in cellular swelling, possibly due to activation of ion exchange mechanisms and increased intracellular o~m o l a r i t y .~~~,~~~ Due to the higher concentration of glycogen in astrocytes than in other cells in the CNS, this effect is most notable in these cells. 1 no acid neurotransmitters, such as glutamate, is probably a major factor in certain types of CNS injury, including hypoxia-ischemia, hypoglycemia, e t~.~~,~' ,~~,~~,~~~,~~~ Neurons possess a variety of receptors for these neurotransmitter^.^,^^ These receptors are grouped into two broad categories, ionotropic and metabotropic, which are further subdivided based on their ability to be stimulated by various agonists such as n-methyl-D-aspartate (NMDA), kainate, etc. Stimulation of ionotropic receptors results in increased permeability to certain ions such as Ca", K', and Na+, with the ultimate effect of increasing [Ca2+],.50 Metabotropic receptor stimulation, however, also increases [Ca2+],, but this indirect effect results from increased cytosolic concentrations of inositol 1,4,5-triphosphate and diacylgly~erol.~~ Increased neuronal [Ca"], has a stimulatory effect on various enzymes, including phospholipases, diacylglycerol lipase, plasmalogenase, protein kinases, and Enhanced or persistent stimulation of excitatory amino acid receptors such as occurs in these types ofCNS injury results in cytosolic calcium overload, degradation of membrane phospholipids with release of free fatty acids such as arachidonate, increased concentrations of polyunsaturated free fatty acids, and formation of lipid peroxides and free radicals, which contribute to the neuronal damage.27.50.207,263 Stimulation of the NMDA-type receptor is thought to be responsible for much of the neuronal necrosis mediated by these pert~rbations,~~.~'.~~-~~ but other types of receptors also may be i r~v o l v e d .~~.~~, '~'
Astrocytes are obviously relatively resistent to the deleterious effects of excitatory amino acid receptor stimulation in these types of CNS injury. Although astrocytes have glutamate receptors, the NMDA receptor has not been identified in these cells, and differences in astrocytic receptors may help explain the relative resistance of astrocytes as compared with that of neurons.5o Astrocytes may help protect neurons in these situations. Anoxic conditions and stimulation of astrocytic glutamate receptors result in increased concentration of glutamine synthetase.'66.196 Despite such adaptive responses to increased glutamate and the various mechanisms for control of ionic balance, pH, and osmolarity, severe injury exceeds the capacity of astrocytes to maintain homeostasis. Increased [Ca2+], in astrocytes resulting from glutamate receptor stimulation may damage these cells7L~87~110. 120 Much has been said concerning the importance of gap junctions and the glial syncytium in maintaining the cerebral microenvironment. How are gap junctions affected by the events that occur during hypoxia-ischemia, etc.? Gap junctions are believed to close following acidification of the cytoplasm and in response to activation of protein kinase C.48,209 Closing of these junctions may assist in the containment of this disturbed milieu and limit its spread to adjacent areas of the CNS.
Astrocytic hypertrophy-hyperplasia
Astrocytic hypertrophy (astrogliosis) and proliferation (astrocytosis) are common responses to injury and cellular necrosis in the CNS. By convention, the term gliosis has been used synonymously with astrogliosis. Gliosis, however, makes no distinction between responses of micro-and astroglia and to avoid confusion, astrogliosis may be preferred when referring to a strictly astrocytic response. Many of the injuries that initiate astrocytic swelling may progress further to hypertrophy-hyperplasia with longer survival times such that both reactions may be seen in combination. In disorders with a more prolonged clinical course, hyperplasia and proliferation may be the sole or primary astrocytic reactions and can even be the predominant lesions in some diseases. This section covers the basic characteristics and current views concerning this type of astrocytic response as well as the time course and determinants of these reactions. This astrocytic response varies, depending on the nature of the CNS injury. Penetrating wounds, tumors, and slowly progressive neurodegenerative diseases result in different patterns of reaction. In addition, heterogeneity of astrocytes and/or differences in neuron-glia interactions in different areas of the brain influence these responses.
Astrocytic hypertrophy. Many authors refer to hypertrophied astrocytes as reactive. The most distinguishing features of reactive astrocytes are the dramatic Vet Pathol 3 12, I994 increase in glial fibrils throughout the cytoplasm and the increased width, length, number, and complexity of the processes. As a result, the cell bodies and processes enlarge, become increasingly eosinophilic, and may even be visible with hematoxylin and eosin. Astrocytic hypertrophy is best viewed, however, after metallic impregnation with such products as Cajal's gold sublimate (Fig. 2) , special stains such as Holzer (Figs.  3, 4) or Mallory's phosphotungstic acid, and immunocytochemical staining for glial fibrillary acidic protein (GFAP) (Fig. 5 ). Increased and often pronounced staining for GFAP may occur very early in the course of events, even in protoplasmic astrocytes that normally display only slight or undetectable reactivity.12,141,213 This response is so pronounced that some authors have defined astrocytic hypertrophy on the basis of increased GFAP immunostaining. Immunoreactivity of vimentin, another intermediate filament protein, is normally expressed only during certain early stages of astrocytic differentiation but not in the normal mature brain. Reactive astrocytes, such as those immediately surrounding cerebral stab wounds or in other areas with various types of injury, display vimentin r e a~t i~i t y .~~~~~~~~~~~~~~~~~~~~~
The presence of GFAP but not vimentin is necessary for but not the sole determinant of the formation of astroglial processes.8s Another 48-kd protein associated with intermediate filaments is expressed in reactive astrocytes. I This protein may be responsible for cross-linking intermediate filaments and may be related to cell process formation. A variety of biochemical changes are present in reactive astrocytes, including elevated DNA, oxidoreductive enzyme activity, glutamine synthetase and other enzymes, glycogen and glucose utilization, and apoli-In addition to the study of astrocytic hypertrophy in vivo, astrocytes grown in cell culture can be stimulated to display reactive changes, providing another means of studying this process. Astrocytes in culture typically have a flat, polygonal morphology from which small cells resembling normal fibrous astrocytes may develop.36.45,52.53 Exposure of these cells to extracts from injured CNS t i~~~e~~.~~~ or to dibutyryl results in a change from small flat polygonal cells to large stellate process-bearing astrocytes similar to those observed in vivo. These cells display increased GFAP and vimentin immunoreactivity and expression of the 48-kd filament-associated protein typical of reactive astr0cytes.l Treatment of cultured astrocytes also increases the levels of certain enzymes, e.g., glutamine synthetase, associated with the reactive Astrocytic hyperplasia. Do astrocytes proliferate in response to CNS injury and disease? The answer is a qualified yes; astrocytes do proliferate in response to CNS injury but not in all instances. The presence or poprotein E mRNA.45.147.188.I95.I99.2 13.216 absence of astrocytic hyperplasia and the magnitude of the response depends on several factors, including age of the i n d i v i d~a l ,~~.~~.~~. '~~ specie^,^^.^^' type of injury,85 and area of the brain.77.1h7.190,248 For many years, astrocytic proliferation in response to injury was thought to occur by amitotic division. This idea was based on the fact that mitoses were rarely if ever observed in the brain and that DNA replication was not associated with demonstrable mitotic activity. This erroneous belief was challenged by the demonstration of prominent astrocytic mitotic activity in perfusion-fixed brains studied at various times after needle p~ncture.'~ Any delay between death and fixation of the CNS reduced the chances of observing m i t o s e~. '~.~~~ Other questions might be asked. What is the source of astrocytes in areas of astrogliosis and are these cells derived from mature astrocytes or do they originate from precursor cells? Are there differences in the ability of protoplasmic and fibrous or type 1 and type 2 astrocytes to contribute to these lesions? Studies to address these specific questions are limited. There is evidence that proliferating cells can arise from mature astrocytes as well as precursors and from fibrous as well as protoplasmic astrocytes. l B . I 1y,12y.141.147.159. 186 Additionally, type 1 astrocytes are believed to be the primary cells responsible for formation of a glial scar in white matter areas such as the optic nerve and corpus callosum of the rat. 141,147.163 Whether this is true for other brain regions and in other species remains to be determined. Based on the finding that astrocytes can migrate up to 0.72-0.76 mm/day following transplant a t i~n ,~~.~~ the possible contribution of migratory astrocytes has been discussed. 147 Time course of astrocytic hypertrophy-hyperplasia.
The considerable variability in the astrocytic reaction depends on a number of factors. Despite these variations, some general conclusions can be made concerning the temporal and spatial patterns of the response. The earliest studies indicated that astrocyte proliferation begins as early as the fourth day following a cerebral stab wound.40 Proliferation certainly begins during the first week,213 and some studies indicate a range of 2 to 4 d a y~.~~J~~.~~~.~~~ Astrocytic hypertrophy may also be observed soon after injury. With special stains, reactive astrocytes may be seen by 4 days, with the maximal response occurring at 14 day^.^,^^^ This response may then diminish by the 28th day. Immunocytochemical staining for GFAP and vimentin suggests that increased reactivity may be observed as early reactivity is not limited to the area of cerebral damage but can rapidly spread throughout the ipsi-latera189J44.154.248 and in some cases contralateral cerebral cortices. 144 The intensity of GFAP reactivity diminishes by 2 to 3 weeks but may persist for up to 6 as 1 to 4 days.12.89.141.144.147.187.1y5. 248 Increased GFAP or 8 ~e e k~.~~.~~~,~~~, '~~, I~~ Increased vimentin immunoreactivity is usually only transiently expressed near the region of injury but may persist for up to 6 weeks in some brain regions. 195, 248 Determinants of astrocytic hypertrophy-hyperplasia.
These responses of the astrocyte are by no means stereotyped. Factors such as age, species, type of injury, and regional differences in the CNS affect these responses in different ways. There is no doubt that heterogeneity of astrocytes and differences in neuron-astroglia interactions influence these reaction^.^^,^^^ Astrocytic reactions after brain injury may in some ways recapitulate events during normal development. During organogenesis and maturation of the brain, neuronal and astroglial development coincide such that there is near complete investment of certain neurons such as cerebellar Purkinje cells by astrocytic processes, whereas cerebellar granule cells are almost void of this covering.167 This developmental process has led to the theory that certain neurons release mitogens or mitogenic inhibitors, and this theory has been expanded to include injury-induced astrogliosis. 167, 218 In support of this theory, media from cultured granule cells release a substance that inhibits proliferation of type 1 but not type 2 astrocytes. 167.218 In another report, inhibition of astrocytic proliferation required membrane contact between astrocytes and granule cells.84 Other studies have indicated that injured neurons release a substance that causes astrocytic proliferation.167 Neuron-astroglia populations in specific brain regions may reflect a balance. Loss of neurons or neuronal-astroglial membrane contacts may upset this balance in favor of increased number of a s t r o~y t e s .~~,~~~ A variety of factors have been identified that have stimulatory and/or inhibitory effects on astrocytic proliferation, hypertrophy, or other responses to brain injury. These factors include secretion of neurotrophic factors, concentrations of certain enzymes such as glutamine synthetase, and expression of major histocompatibility complex antigens ( Table 4 ). These factors could orchestrate the occurrence and magnitude of the astrocytic reactions in CNS disease. The astrocytic response is not stereotyped, however. Some studies indicate that astrocytes cultured from newborn animals proliferate in response to interleukin-1, whereas those from adult animals are u n r e s p~n s i v e .~~ Most studies of the effects of transforming growth factor-beta (TGFb) on astrocytic proliferation have revealed an inhibitory response. 1 2 5~1 4 0 . 1 6 8 Another study, however, indicated a stimulatory effect on cellular proliferation of astrocytes cultured from brain stem, whereas TGFb had little effect on astrocytes cultured from forebrain. Io3 Additionally, interactions among these factors could alter the astrocytic response. Although TGFb in one study had a slight negative effect on astrocytic growth, it potentiated the proliferative response of astrocytes to basic fibroblast growth factor but not to others, including epidermal and platelet-derived growth factors and thrombin. 125 Additional information regarding these factors can be found in the lists of references in Table 4 .
Primary Roles for Astrocytes in Disease
Astrocytes play a fundamental part in many aspects of central nervous system (CNS) disease. Astrocytic swelling and hypertrophy-hyperplasia are two common responses to several types of injury. These cells may also play more specific primary roles in a variety of CNS diseases. I56 
Astrocytes and seizures
One of the mechanisms proposed for convulsive seizures is that the heightened, uncontrolled spread of neuronal activity results from abnormalities in the neural rnicroen~ironrnent.~~~ Theories linking astrocytes to seizure activity rest largely on the role of astrocytes in regulating the extracellular milieu of ions and neurotransmitters. Astrocytes from epileptic foci display morphologic changes that include abnormal numbers and distribution of orthogonal arrays. 252 The density of arrays is increased at the pial surface as compared with normal brain and among neuronal processes where they are normally lacking or few in number.lZh These findings suggest an abnormality in the astrocytic spatial buffering system. Astrocytes in epileptic foci may also have decreased extracellular K+ concentration ([K+],)-stimulated Na+-K+-ATPase act i~i t y .~~.~~~ Glia from audiogenic seizure-prone mice or from certain epileptic foci display increased carbonic anhydrase enzyme a~t i v i t y .~~.~~~.~~~ This increased activity may represent an adaptive response to heightened neuronal activity. However, low doses of acetazolamide, an inhibitor of this enzyme, have anticonvulsant properties (for further discussion, see above references).
Excitatory amino acids may play a role in seizures. Astrocytes cultured from audiogenic seizure-prone mice display increased glutamate uptake. This increase may be a protective mechanism because overall glutamate concentrations are increased in the cerebral cortex of these mice as compared with normal strains.80 Substances such as methionine sulfoximine, iron, and lead, which inhibit the astrocytic enzyme glutamine synthetase and interfere with glutamate and ammonia metabolism, clearly are able to induce sei-ZUreS.47.83. 241 ,252.253 Although the exact role of astrocytes in epilepsy and seizures is unknown, these examples illustrate areas of active research and mechanisms by which these cells may contribute to the pathophysiology of seizures.
Astrocytes and liver disease
A variety of biochemical abnormalities are thought to take part in the neurologic disturbances secondary to liver disease. Of these, hyperammonemia has traditionally received considerable attention and certainly is a factor in acute hepatic failure and in liver disorders with a more protracted clinical course.78~7y~177~178~180 Astrocytic changes are often the most prominent and consistent brain lesions observed in these diseases. In diseases having an acute clinical course, such as fulminant hepatic failure and Reye's syndrome, astrocytic swelling and cerebral edema are common finding^.^^^.'^^ In diseases with a more pro-longed course (hepatic encephalopathy), Alzheimer type I1 astrocytic change is the most prominent and often the sole lesion. 177~178, 180 Alzheimer type I1 astrocytes have swollen watery nuclei with marginated chromatin that may be irregular in shape and contain glycogen, often prominent nucleoli, and little discernible cytoplasm in hematoxylin and eosin-stained ~e c t i o n s .~~~~~~ The ultrastructural astrocytic changes have been previously described. 181.276 The astrocytic response in hyperammonemia and hepatic disease appear to be unique in that it is associated with a selective decrease of glial fibrillary acidic protein in gray matter areas of the brain and experimentally in cell culture. 124.184 The relationship of astrocytic changes to these diseases is not surprising considering the high activity in astrocytes of glutamine synthetase, the key enzyme responsible for ammonia metabolism in the b~a i n . "~.~~~ Additionally, experimental elevation of brain ammonia by inhibitors of the enzyme results in enhanced immunoreactivity for glutamine synthetase in brain areas displaying Alzheimer type 11-like astrocytic change.271 These ammonia-induced changes may interfere with certain critical astrocytic functions such as neurotransmitter uptake and water, ionic, pH, and osmotic regulation.'* There is also evidence that hyperammonemia impairs astrocytic metabolism of glutamate."l One mechanism by which ammonia may exert an adverse affect is by interfering with Ca2 + homeostasis.I8'
Astrocytes and neurodegenerative diseases
Neurodegenerative diseases are characterized by the degeneration and loss of neurons, often having specific distinguishing neurotransmitter and biochemical features, in specific areas of the CNS. Astrocytes have been incriminated in two such disorders, a toxin-induced Parkinson's disease and Huntington's chorea.
Ingestion of 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a biproduct in the synthesis of certain analgesics, results in degeneration of dopaminergic neurons in the pars cornpacta of the substantia nigra and duplicates many of the clinical, morphologic, and biochemical parameters of Parkinson's disease.88~208~228 Further studies have shown that a metabolite of MPTP, 1 -methyl-4-phenylpyridinium ion (MPP'), is the toxin actually responsible for the neuronal degeneration. After conversion, MPP' is taken up by the catecholamine system in dopaminergic neurons, where it binds to neuromelanin and neuronal death Several lines of evidence link astrocytes to this toxin-induced degeneration of neurons. First, the enzyme monoamine oxidase-B, which is responsible for the conversion of MPTP to MPP+, is localized in astro-,-,,tes. 17.208.210 Second, destruction of astrocytes by the gliotoxin alpha-amino adipic acid protects against MPP+-induced n e u r o t~x i c i t y .~~~ The most characteristic morphologic feature of Huntington's disease is loss of mainly small to medium neurons in the neostriatum, which is accompanied by relatively specific biochemical changes. Based on experimental studies that duplicate many of these biochemical and morphologic parameters, excitatory and potentially toxic amino acids or their analogs, including neurotransmitter glutamate, L-pyroglutamic acid, and the tryptophan metabolite quinolinic acid, have been proposed as possible endogenous neurotoxins in Huntington's disease.44Jy3,21 5, 231, 258, 266 Mechanisms for the neurodegeneration in this disorder generally revolve around increased synthesis and release or decreased uptake, metabolism, and clearance of these amino acids which allows them to accumulate to neurotoxic levels. Astrocytes are involved in the uptake and metabolism of glutamate, and an abnormality in uptake has been proposed. I y 3 Enzymes in the kynurenine pathway responsible for quinolinic acid synthesis and degradation (3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyltransferase, respectively) are present in a~t r o c y t e s .~~~.~~~ Activity of the synthetic enzyme is increased in the brains of Huntington's disease victims and this activity is most pronounced in the s t r i a t~m .~~~
Astrocytes in demyelinating disease
As antigen-presenting cells, astrocytes may participate in inflammatory and immune-mediated diseases within the CNS.15,55,56,170.214 A key to this antigen-presenting function is the ability to express antigens of the major histocompatibility complex (MHC) ( Table 3) for T-lymphocyte recognition. Class I MHC antigens are expressed by many cell types throughout the body and are necessary for recognition by cytotoxic-suppressor T-cells. Astrocytes in culture induced to express MHC class I antigens are susceptible to being killed by cytotoxic T-lymphocytes.222 Class I1 MHC expression is limited primarily to cells involved in immune function and is required for recognition by helper-inducer T-lymphocytes. The induction of class I1 MHC antigens on astrocytes by a variety of factors, including interferon (1FN)-gamma, tumor necrosis factor (TNF)enhanced IFN-induced responses, and certain virus-e~,2.54,58.59. 142, 222, 259, 273 suggests that astrocytes may be involved in immune-mediated disease. In experimental allergic encephalomyelitis (EAE), astrocytes and other cells, including microglia and endothelium, express MHC class I1 mo1ecules.54~5y~155~156 Cells that express class I1 antigens are also present in active lesions of multiple sclerosis (MS), and at least some of these appear to be astrocytes.132 There is controversy, however, concerning which cells indigenous to the CNS, astrocytes or microglia, actually serve as antigen-presenting cells in these diseases. 155, 156 Several lines of evidence support an astrocytic role. Demyelination is related to the ease with which astrocytes can be induced to express MHC class I1 antigens by IF% in Theiler's disease-suspectible mouse strains15 or in EAE-susceptible mouse and rat strains153 as compared with resistant animals. Furthermore, demyelination following JHM viral infection depends on the ease with which the coronavirus can directly induce MHC class I1 antigen expression by astrocytes in susceptible versus resistant rat These findings do not negate or lessen the contribution of microglia in these diseases. Variations between in vivo and in vitro studies could be due at least in part to down regulation of astrocytic MHC class I1 antigen expression by norepinephrine, glutamate, and transforming growth factor-beta providing some local control over immune-mediated events in the CNS.Io3J3'
The additional ability of astrocytes to inductively secrete cytokines such as IFN-alpha and beta, interleukin (1L)-1, -3, and -6, TNF, and adhesion molecules could serve to further modulate cellular and immune these, TNF has received attention in relation to demyelinating diseases because of its cytotoxicity for oligodendrocytes but not astrocytes and its ability to damage myelin.217,234,235 Astrocytes from rat strains susceptible to EAE express TNF in response to IFNgamma or combined IFN-gamma and IL-1 beta, whereas astrocytes from an EAE-resistant rat strain do not.33 Additionally, in a model of EAE, mice treated with anti-TNF antibody failed to develop lesions. 236 This study did not address TNF production by cells indigenous to the CNS, however. Furthermore, other cells in the CNS produce TNF, and some, such as microglia, produce this cytokine at much higher concentrations than do astrocytes.226 As a result, the specific contribution of astrocytic TNF production in demyelinating disease is difficult to ascertain. As far as other astrocytic products are concerned, adhesion molecules may be involved in immune-mediated demyelinating disease. In addition to intercellular adhesion molecule, astrocytes in normal human white matter express another proteoglycan, termed CD44 antigen, that is believed to be involved in adhesion of lymphocytes to e n d o t h e l i~m .~~ There is increased expression of CD44 antigen by reactive astrocytes in active lesions of MS.65 responses in these diseases.32.54.57-59. 136.217.222.225.226 Of
Summary
Considerable knowledge has been acquired in recent years concerning astrocytic functions and their reactions to and participation in diseases of the central nervous system (CNS). During this same time period, few articles in the veterinary literature have dealt specifically with astrocytes and their reactions or contri-butions to disease. Despite the fact that much of the information in this review has been derived from in vitro studies or from studies using a variety of laboratory animals, the knowledge is just as applicable to animals as it is to human beings. Prior to or in conjunction with studies of astrocytes in animal diseases, questions concerning these cells in the normal CNS of a variety of animals must be addressed. Do astrocytes in the gray matter of normal animals express glial fibrillary acidic protein (GFAP) at appreciable concentrations, as determined by immunocytochemical staining?lO' If so, are there regional, age, or species variations?
Recent knowledge coupled with technical advances in the study ofastrocytic reactions in disease may modify our morphological interpretations in some instances. Alzheimer type I1 astrocytic change has been identified in the brains of animals with hepatic failure based on the morphologic appearance of the astrocytic nuclei. With the relatively recent finding of decreased GFAP expression in these cells, can we as veterinary pathologists accurately differ Alzheimer type I1 change from hypertrophy without im m unoc y t oc hem ical staining?loO Innumerable questions such as these arise for which there are, as yet, no concrete answers.
No detailed study of disease in the CNS can be complete without consideration of all participating cell types, neurons as well as neuroglia. It is hoped that this review will instill a new appreciation for the astrocyte as a critical cell in the CNS. Future in-depth investigations of diseases in the CNS should include a detailed study of the astrocyte. 
